217 related articles for article (PubMed ID: 16950806)
41. DNA topoisomerases I and II in human mature sperm cells: characterization and unique properties.
Har-Vardi I; Mali R; Breietman M; Sonin Y; Albotiano S; Levitas E; Potashnik G; Priel E
Hum Reprod; 2007 Aug; 22(8):2183-9. PubMed ID: 17656417
[TBL] [Abstract][Full Text] [Related]
42. DNA topoisomerase II is essential for preimplantation mouse development.
St Pierre J; Wright DJ; Rowe TC; Wright SJ
Mol Reprod Dev; 2002 Mar; 61(3):347-57. PubMed ID: 11835580
[TBL] [Abstract][Full Text] [Related]
43. Protective effect of selected flavonoids on in vitro daunorubicin-induced cardiotoxicity.
Mojzisová G; Mirossay L; Kucerová D; Kyselovic J; Mirossay A; Mojzis J
Phytother Res; 2006 Feb; 20(2):110-4. PubMed ID: 16444662
[TBL] [Abstract][Full Text] [Related]
44. Syntheses and biological activities of disaccharide daunorubicins.
Zhang G; Fang L; Zhu L; Aimiuwu JE; Shen J; Cheng H; Muller MT; Lee GE; Sun D; Wang PG
J Med Chem; 2005 Aug; 48(16):5269-78. PubMed ID: 16078845
[TBL] [Abstract][Full Text] [Related]
45. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
Shuai L; Wang S; Zhang L; Fu B; Zhou X
Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
[TBL] [Abstract][Full Text] [Related]
46. Flavonoids as enhancers of x-ray-induced cell damage in hepatoma cells.
van Rijn J; van den Berg J
Clin Cancer Res; 1997 Oct; 3(10):1775-9. PubMed ID: 9815563
[TBL] [Abstract][Full Text] [Related]
47. Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity.
Webb MR; Ebeler SE
Biochem J; 2004 Dec; 384(Pt 3):527-41. PubMed ID: 15312049
[TBL] [Abstract][Full Text] [Related]
48. Induction of diplochromosomes in mammalian cells by inhibitors of topoisomerase II.
Sumner AT
Chromosoma; 1998 Dec; 107(6-7):486-90. PubMed ID: 9914381
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory activities against topoisomerase I and II by isoaurostatin derivatives and their structure-activity relationships.
Suzuki K; Okawara T; Higashijima T; Yokomizo K; Mizushima T; Otsuka M
Bioorg Med Chem Lett; 2005 Apr; 15(8):2065-8. PubMed ID: 15808469
[TBL] [Abstract][Full Text] [Related]
50. Flavonoids, taxifolin and luteolin attenuate cellular melanogenesis despite increasing tyrosinase protein levels.
An SM; Kim HJ; Kim JE; Boo YC
Phytother Res; 2008 Sep; 22(9):1200-7. PubMed ID: 18729255
[TBL] [Abstract][Full Text] [Related]
51. Synthetic lanostane-type triterpenoids as inhibitors of DNA topoisomerase II.
Wada S; Tanaka R
Bioorg Med Chem Lett; 2005 Jun; 15(12):2966-9. PubMed ID: 15914002
[TBL] [Abstract][Full Text] [Related]
52. DNA topoisomerase II is required for the G0-to-S phase transition in Drosophila Schneider cells, but not in yeast.
Hossain MS; Kurokawa K; Akimitsu N; Sekimizu K
Genes Cells; 2004 Oct; 9(10):905-17. PubMed ID: 15461662
[TBL] [Abstract][Full Text] [Related]
53. Increased levels of DNA topoisomerases in cultured CHO cells treated with the antitumour drug 5-azacytidine.
Piñero J; López-Baena M; Ortiz T; Mateos S; Cortés F
Cytobios; 1999; 97(385):103-15. PubMed ID: 10418121
[TBL] [Abstract][Full Text] [Related]
54. Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
Constantinou A; Mehta R; Runyan C; Rao K; Vaughan A; Moon R
J Nat Prod; 1995 Feb; 58(2):217-25. PubMed ID: 7769390
[TBL] [Abstract][Full Text] [Related]
55. Emerging DNA topisomerase inhibitors as anticancer drugs.
Denny WA
Expert Opin Emerg Drugs; 2004 May; 9(1):105-33. PubMed ID: 15155139
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of topoisomerase II by 8-chloro-adenosine triphosphate induces DNA double-stranded breaks in 8-chloro-adenosine-exposed human myelocytic leukemia K562 cells.
Yang SY; Jia XZ; Feng LY; Li SY; An GS; Ni JH; Jia HT
Biochem Pharmacol; 2009 Feb; 77(3):433-43. PubMed ID: 19014910
[TBL] [Abstract][Full Text] [Related]
57. Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine.
Cortázar TM; Coombs GH; Walker J
Exp Parasitol; 2007 Aug; 116(4):475-82. PubMed ID: 17466980
[TBL] [Abstract][Full Text] [Related]
58. Anticancer activity of botanical alkyl hydroquinones attributed to topoisomerase II poisoning.
Huang CP; Fang WH; Lin LI; Chiou RY; Kan LS; Chi NH; Chen YR; Lin TY; Lin SB
Toxicol Appl Pharmacol; 2008 Mar; 227(3):331-8. PubMed ID: 18164362
[TBL] [Abstract][Full Text] [Related]
59. Topoisomerase II inhibitors.
Clapp JM; Hande KR
Cancer Chemother Biol Response Modif; 2002; 20():125-49. PubMed ID: 12703203
[No Abstract] [Full Text] [Related]
60. Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone.
Verschoyle RD; Greaves P; Cai H; Borkhardt A; Broggini M; D'Incalci M; Riccio E; Doppalapudi R; Kapetanovic IM; Steward WP; Gescher AJ
Cancer Chemother Pharmacol; 2006 Jan; 57(1):1-6. PubMed ID: 16001171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
